Histidinemia

Histidinemia is a rare hereditary metabolic disorder characterized by a deficiency of the enzyme histidase, which is necessary for the metabolism of the amino acid histidine. The majority of individuals are asymptomatic.

Histidase Deficiency Syndrome; Histidine Ammonia-Lyase Deficiency; HAL Deficiency; HIS Deficiency; Hyperhistidinemia.

Histidinemia is inherited as an autosomal recessive trait and is considered one of the most common inborn errors of metabolism. It is present at birth and affects males and females in equal numbers. It is now thought to be a primarily benign disorder. In a study of more than 20 million newborns, the incidence of this disease was estimated to be 1:11,500 births. This medical condition seems to be most prevalent among people of French Canadian or Japanese descent. In the Province of Quebec, Canada, the incidence is estimated approximately 1:8600 infants. In Japan, the incidence is reported to be 1:9500 infants in Japan.

Histidinemia is considered a benign condition. For years, it was believed that mental retardation and speech defects were associated with histidinemia; however, it has now been established that these findings are coincidental. Infants with histidinemia are asymptomatic. Individuals with histidinemia have elevated levels of the amino acid histidine in the blood and excessive amounts of histidine, imidazole pyruvic acid, and other imidazole metabolism products in the urine.

No specific anesthetic considerations with this medical conditions.

Histidinuria as A Result of Renal Tubular Defect: Disorder characterized by mild mental retardation and histidinuria despite normal blood levels. Histidine loading showed impaired intestinal absorption. Clinical findings include myoclonic seizures, sensorineural deafness, thin upper lips and long shallow philtrum, and short thick fingers and toes. Radiologically, the middle phalanges are short, rounded, and abnormally shaped. The inheritance is presumably autosomal recessive transmission.